Better Science, Better Health: New Trial Pathways and Better Patient Data
Speakers:
Edward Abrahams
President,
Personalized Medicine Coalition
Ifty Ahmed
CEO,
Pow Health
Mohammad Al-Ubaydli
CEO,
Patients Know Best®
James Anderson
Director of EU Industry & External Partnerships,
GSK
Andrea Beyer
Expert,
Benefit Risk Assessment
Richard Barker
Director,
CASMI
Jack Bowman
CEO,
Handle my Health
Finn Børlum Kristensen
Executive Director,
EUnetHTA
Helmut Brand
President,
International Forum Gastein
Wendy Currie
Editor in Chief,
Health Policy & Technology
Audencia, France
John Crawford
Healthcare Industry Leader,
IBM Europe
Hans-Georg Eichler
Senior Medical Officer,
European Medicines Agency
Laura Esserman
Breast Cancer Center Director (I-Spy)
University of California San Francisco
Gary Finnegan
Journalist, Editor and Author
George Freeman
Parliamentary Under Secretary of
State for Life Sciences,
UK Government
Pat Furlong
Founding President and CEO,
Parent Project Muscular Dystrophy
Sarah Garner
Associate Director, Research and Development,
National Institutes of Clinical Excellence
Michel Goldman
Executive Director,
IMI
Jeremy Haigh
European Chief Operating Officer, Research & Development
Amgen Ltd.
Joel Haspel
Director Strategy & Business
Development EMEA,
Oracle Health Sciences
Adam Heathfield
Senior Director, Global Health and Value Innovation Center,
Pfizer
Ryan Hohman
Managing Director, Policy & Public Affairs,
Friends of Cancer Research US
Alastair Kent
Director,
Genetic Alliance UK
Faraz Kermani
Senior Editor Europe,
Elsevier – The Pink Sheet
Yann Le Cam
CEO,
Eurordis
Sandrine Marreaud
Head of Medical and Pharmacovigilance Department,
EORTC
Jillian Oderkirk
Senior Analyst, Health Division,
OECD
Bettina Ryll
Founder,
Melanoma Patient Network Europe
Duane Schulhtess
Managing Director,
Vital Transformation
Cornelius Schmaltz
Deputy Head of Unit of the Fighting Infectious Diseases and Global
Epidemics unit, European Commission
Nathalie Seigneuret
Senior Scientific Project Manager,
Innovative Medicines Initiative (IMI)
Paolo Daniele Siviero
Head of Office Pharmaceutical Policy,
Italian Medicines Agency
Olga Solomon
Deputy Head of Unit,
DG Health and Consumers,
Medicinal products, authorisations – ema (D5), European Commission
Sir Richard Thompson
Immediate Past President,
Royal College of Physicians
Richard Torbett
Chief Economist,
EFPIA
Mark Trusheim
Visiting Scientist,
MIT Sloan School of Management
MIT Center for Biomedical Innovation
Bart Vannieuwenhuyse
Senior Director Health Information Sciences,
Janssen Pharmaceutical Companies
of Johnson and Johnson
Andrew Ward
Pharmaceuticals Correspondent,
Financial Times
Tim Williams
Head of Research,
Clinical Practice Research Datalink
(CPRD)
Geoff Wilson
HTA Task Force Leader,
COCIR
Stephen Whitehead
Chief Executive,
ABPI
In collaboration with:
